TARA – protara therapeutics, inc. (US:NASDAQ)
Stock Stats
News
3/19
08:08 am
tara
Medium
Protara Therapeutics Announces Encore Presentation of Results from THRIVE-1 Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support [Yahoo! Finance]
3/19
08:00 am
tara
High
Protara Therapeutics Announces Encore Presentation of Results from THRIVE-1 Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support
3/14
08:02 am
tara
Low
Protara Therapeutics, Inc. (NASDAQ: TARA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
3/11
08:56 am
tara
High
Protara Therapeutics, Inc. (NASDAQ: TARA) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $22.00 price target on the stock.
3/6
08:12 am
tara
Medium
Protara Therapeutics, Inc. (NASDAQ: TARA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
11/12/2024
08:00 am
tara
-4.1%
IN-LINE
8/6/2024
08:00 am
tara
0.0%
BEAT
5/2/2024
08:00 am
tara
-0.3%
BEAT
3/14
10:01 am
Initiates
Overweight
Cantor Fitzgerald
Medium
3.6%
3/14
08:02 am
Initiates
Overweight
Cantor Fitzgerald
Low
0.5%
3/14
06:02 am
Initiates
OVERWEIGHT
CANTOR FITZGERALD
Low
2.1%
3/6
08:12 am
Reiterates
Buy
Buy
HC Wainwright
Medium
8.0%
3/28
04:12 pm
tara
Medium
Form 4 Protara Therapeutics, For: Mar 26 Filed by: Zummo Jacqueline
3/28
04:05 pm
tara
Medium
Form 4/A Protara Therapeutics, For: Jan 24 Filed by: Shefferman Jesse
3/28
04:05 pm
tara
Medium
Form 4/A Protara Therapeutics, For: Jan 24 Filed by: Zummo Jacqueline
3/28
04:05 pm
tara
Medium
Form 4/A Protara Therapeutics, For: Jan 24 Filed by: Fry Hannah
3/28
04:05 pm
tara
Medium
Form 4/A Protara Therapeutics, For: Jan 24 Filed by: Fabbio Patrick
Show more
Top News Gainers
3/23 Form 8-K ArTara Therapeutics, For: Mar 18 14.2%
1/21 Form SC 13D ArTara Therapeutics, Filed by: Opaleye Management Inc. 12.8%
2/4 Verona Pharma plc (NASDAQ: TARA) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 6.9%
3/30 Form 8-K ArTara Therapeutics, For: Mar 26 6.5%
4/21 Verona Pharma plc (NASDAQ: TARA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.7%
2/11 Form 424B3 ArTara Therapeutics, 4.6%
4/2 ArTara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 4.3%
1/15 Form S-8 ArTara Therapeutics, 3.7%
2/14 Form SC 13G/A ArTara Therapeutics, Filed by: INTERSOUTH PARTNERS VI LP 2.7%
4/23 Form DEF 14A ArTara Therapeutics, For: Jun 09 2.5%
Top News Decliners
2/21 Form SC 13G ArTara Therapeutics, Filed by: Ikarian Capital, LLC -7.6%
4/9 Form SEC STAFF LETTER ArTara Therapeutics, -6.1%
3/20 Form 10-K ArTara Therapeutics, For: Dec 31 -4.6%
4/18 Verona Pharma plc (NASDAQ: TARA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $27.00 price target on the stock. -4.5%
1/30 Form S-3 ArTara Therapeutics, -4.0%
1/13 Form 3 ArTara Therapeutics, For: Jan 09 Filed by: Opaleye, L.P. -3.6%
2/18 Form 4/A ArTara Therapeutics, For: Jan 09 Filed by: Shefferman Jesse -3.1%
1/27 Form SC 13D/A ArTara Therapeutics, Filed by: Opaleye Management Inc. -1.6%
1/16 Form SC 13G ArTara Therapeutics, Filed by: Wilson Donald R. Jr. -0.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3